Literature DB >> 671584

Heat inactivation of vaccinia virus particle-associated functions: properties of heated particles in vivo and in vitro.

J M Harper, M T Parsonage, H R Pelham, G Darby.   

Abstract

The heat inactivation characteristics of several vaccinia virus particle-associated functions known to be involved in the transcription of the genome were examined. All functions were more resistant to heat than infectivity. Noninfectious particles were generated which exhibited significant levels of activity of all enzymes examined, and their properties were investigaed both in vitro and in vivo. RNA was synthesized in vitro by such particles, although transport of the RNA into the surrounding medium was defective. This RNA was larger than that made in normal particles but it was polyadenylated and functioned in vitro as a message coding for normal early proteins. The sequences transcribed were similar to those transcribed in normal particles, and we suggest that the production of abnormally large RNA is due to a defect in transcriptional termination. We could not detect any virus-specific protein or RNA synthesis in cells exposed to these inactivated particles and conclude that the loss of infectivity caused by heating is due to a general decline in the activities of a number of particle functions.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 671584      PMCID: PMC525889          DOI: 10.1128/JVI.26.3.646-659.1978

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Molecular complexity of vaccinia DNA and the presence of reiterated sequences in the genome.

Authors:  L J Grady; E Paoletti
Journal:  Virology       Date:  1977-06-15       Impact factor: 3.616

2.  Use of coupled transcription and translation to study mRNA production by vaccinia cores.

Authors:  H R Pelham
Journal:  Nature       Date:  1977-10-06       Impact factor: 49.962

3.  Replication of vaccinia DNA in mouse L cells. I. In vivo DNA synthesis.

Authors:  M Esteban; J A Holowczak
Journal:  Virology       Date:  1977-05-01       Impact factor: 3.616

4.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

Review 5.  Translational control of protein synthesis.

Authors:  H F Lodish
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

6.  Vaccinia virus polypeptide synthesis: sequential appearance and stability of pre- and post-replicative polypeptides.

Authors:  T H Pennington
Journal:  J Gen Virol       Date:  1974-12       Impact factor: 3.891

7.  Messenger activity of RNA transcribed in vitro by DNA-RNA polymerase associated to vaccinia virus cores.

Authors:  G Jaureguiberry; F Ben-Hamida; F Chapeville; G Beaud
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

8.  In vitro synthesis of a high molecular weight virion-associated RNA by vaccinia.

Authors:  E Paoletti
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

9.  Terminal riboadenylate transferase: a poly A polymerase in purified vaccinia virus.

Authors:  M Brown; J W Dorson; F J Bollum
Journal:  J Virol       Date:  1973-08       Impact factor: 5.103

10.  Elimination of naturally occurring crosslinks in vaccinia virus DNA after viral penetration into cells.

Authors:  B G Pogo
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

View more
  10 in total

1.  Production of prostaglandin E₂ in response to infection with modified vaccinia Ankara virus.

Authors:  Justin J Pollara; April H Spesock; David J Pickup; Scott M Laster; Ian T D Petty
Journal:  Virology       Date:  2012-04-23       Impact factor: 3.616

2.  Some enzymatic activities associated with purified parapoxvirions.

Authors:  H S Caplen; J A Holowczak
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

3.  Extension of the transcriptional and translational map of the left end of the vaccinia virus genome to 21 kilobase pairs.

Authors:  J A Cooper; R Wittek; B Moss
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

4.  Capped and polyadenylated low-molecular-weight RNA synthesized by vaccinia virus in vitro.

Authors:  E Paoletti; B R Lipinskas; D Panicali
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

5.  Cowpox virus inhibits human dendritic cell immune function by nonlethal, nonproductive infection.

Authors:  Spencer J Hansen; John Rushton; Alexander Dekonenko; Hitendra S Chand; Gwyneth K Olson; Julie A Hutt; David Pickup; C Rick Lyons; Mary F Lipscomb
Journal:  Virology       Date:  2011-02-21       Impact factor: 3.616

6.  Efficacy of heat against the vaccinia virus, variola virus and monkeypox virus.

Authors:  G Kampf
Journal:  J Hosp Infect       Date:  2022-06-18       Impact factor: 8.944

7.  Analysis of vaccinia virus transcriptional complexity in vitro and in vivo: characterization of RNase T1-resistant 5'-terminal oligonucleotides.

Authors:  C Whitkop; B R Lipinskas; S Mercer; D Panicali; E Paoletti
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

8.  Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domain.

Authors:  Hua Cao; Peihong Dai; Weiyi Wang; Hao Li; Jianda Yuan; Fangjin Wang; Chee-Mun Fang; Paula M Pitha; Jia Liu; Richard C Condit; Grant McFadden; Taha Merghoub; Alan N Houghton; James W Young; Stewart Shuman; Liang Deng
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

9.  Human neonatal dendritic cells are competent in MHC class I antigen processing and presentation.

Authors:  Marielle C Gold; Tammie L Robinson; Matthew S Cook; Laura K Byrd; Heather D Ehlinger; David M Lewinsohn; Deborah A Lewinsohn
Journal:  PLoS One       Date:  2007-09-26       Impact factor: 3.240

10.  Identification of Toll-like receptor 9 as parapoxvirus ovis-sensing receptor in plasmacytoid dendritic cells.

Authors:  Heiner von Buttlar; Sabine Siegemund; Mathias Büttner; Gottfried Alber
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.